Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Forex Boards
  20/03/2010
08:46:46
Site map		   Help
 
Cadence Pharmaceuticals (MM)
   
To register click here

Cadence Pharmaceuticals Stock Price CADX

Cadence Pharmaceuticals stock quote | Cadence Pharmaceuticals company information | Cadence Pharmaceuticals Stock Chart | Cadence Pharmaceuticals Stock News

Company Description : A biopharmaceutical company, which is focused on in-licensing, developing and commercializing product candidates mainly for use in the hospital setting. url: www.cadencepharm.com

Name:
Cadence Pharmaceuticals (MM)		 Symbol:
NASDAQ:CADX		 Stock Market:
NASDAQ Stock Market		 Type:
Common Stock		 ISIN:
 Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
-0.03-0.348.918.110.719.048.759.0229818315:50:03
To register Click hereRegister for free Cadence Pharmaceuticals stock prices.

Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results
Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the fourth quarter and year ended December 31, 2009. During 2009, Cadence completed...

Free Cadence Pharmaceuticals Stock Charts

Cadence Pharmaceuticals Historical Stock Chart
Cadence Pharmaceuticals Historical Stock Chart
Cadence Pharmaceuticals Monthly Stock Chart
Cadence Pharmaceuticals Monthly Stock Chart		Cadence Pharmaceuticals Intraday stock chart
Cadence Pharmaceuticals Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Cadence Pharmaceuticals stock Price, quotes, trades and FREE Cadence Pharmaceuticals stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Cadence Pharmaceuticals (CADX) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Cadence Pharmaceuticals News & Message Board Discussion

Latest Cadence Pharmaceuticals News Headlines
DateTimeSource
HeadlineMore
03/15/20104:00PMPRNUSCadence Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results
03/08/20104:30PMPRNUSCadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2009 Financial Results on Ma
02/11/20107:30AMPRNUSCadence Pharmaceuticals Receives Complete Response Letter from FDA for Intravenous Acetaminophen NDA
11/13/20097:30AMPRNUSCadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
11/05/20094:01PMPRNUSCadence Pharmaceuticals Reports Third Quarter 2009 Financial Results
10/29/20094:15PMPRNUSCadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results on November 5, 2009
10/28/20096:00PMPRNUSCadence Pharmaceuticals' CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on N
10/20/20095:00PMPRNUSCadence Pharmaceuticals' CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
09/30/20098:00AMPRNUSCadence Pharmaceuticals to Webcast October 7th Analyst Day
09/29/20096:30PMPRNUSCadence Pharmaceuticals' CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6
09/09/20095:00PMPRNUSCadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009
08/05/20094:01PMPRNUSCadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
Latest Message Board Discussions
DateTime
TitleMore
02/11/20108:39AM7:30AM Cadence Pharma receives Complete Response Letter from
11/13/20098:42AMFDA extends review of Cadence's IV drug Acetavance
01/20/200911:58AMHey guys - did you see that announcement
09/15/20088:21PMCadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
08/07/20088:04AMCadence Pharmaceuticals Reports Second Quarter 2008 Financial Results
07/30/20086:00PMCadence Pharmaceuticals Announces FDA Concurrence With Clinical Development
05/07/20082:15PMCadence Pharmaceuticals Reports First Quarter 2008 Financial Results
04/01/20085:05PMCadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
02/15/20088:09AMCadence Pharmaceuticals to Raise up to $49.3 Million
02/10/200810:01AMIs this testing what caused the nosedive? I

Cadence Pharmaceuticals Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Cadence Pharmaceuticals company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Cadence Pharmaceuticals Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  1756 8.907 03/19/2010 4:45PM USD


 



Cadence Pharmaceuticals (MM) Stock Prices supplied by NASDAQ.
Free NASDAQ stock prices are delayed by at least 15 minutes. Realtime NASDAQ stock prices available.
The Spread Bet Centre :: The CFD Centre :: Financial Glossary :: Forex Rates, Charts & News
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright 1999-2010 ADVFN PLC. Copyright Notice & Privacy Policy :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
33 site:2us nasdaq cadx100320 08:46